Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hayat Pharmaceutical Consultants (HPC) provides comprehensive consulting services in CMC development and manufacturing strategies for small molecules, biologics, and ATMPs. The company manages tech transfers and oversees GMP manufacturing from preclinical through commercial stages. It also offers specialized preclinical research services including IND/NDA-enabling toxicology studies as well as early-phase clinical research support. Through partnerships such as with Trial360, HPC conducts global preclinical and clinical trials across a wide range of therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hayat Pharmaceutical Consultants.